These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 436537)
61. [Electrophysiologic effects of intravenous and oral encainide in patients with Wolff-Parkinson-White syndrome and paroxysmal atrial fibrillation]. Chimienti M; Moizi M; Salerno JA; Klersy C; Marangoni E; Previtali M; Montemartini C; Bobba P Cardiologia; 1986 Feb; 31(2):155-61. PubMed ID: 3098424 [No Abstract] [Full Text] [Related]
62. [Evaluation of the efficacy of anti-arrhythmia agents in hyperkinetic ventricular arrhythmia]. Bracchetti D; Mantovani B; Naccarella F; Lombardi G; Palmieri M Boll Soc Ital Cardiol; 1980; Suppl():117-23. PubMed ID: 7349604 [No Abstract] [Full Text] [Related]
63. The effect of intravenous disopyramide phosphate on recurrent paroxysmal tachycardias. Camm J; Ward D; Spurrell RA Br J Clin Pharmacol; 1979 Nov; 8(5):441-9. PubMed ID: 508548 [TBL] [Abstract][Full Text] [Related]
64. Comparative antiarrhythmic effects of intravenously administered lidocaine and procainamide and orally administered quinidine. Schwartz ML; Webb NC; Covino BG; Finck EM; Haider B Am J Cardiol; 1970 Nov; 26(5):520-3. PubMed ID: 4097888 [No Abstract] [Full Text] [Related]
65. Control of ventricular preexcitation and associated arrhythmias by encainide. Roden DM; Duff HJ; Primm RK; Kronenberg MW; Woosley RL Am Heart J; 1981 Oct; 102(4):794-7. PubMed ID: 6792894 [No Abstract] [Full Text] [Related]
66. Wolff-Parkinson and White syndrome. Clinical presentation and management. Bajaj A; Patel JS Cent Afr J Med; 1986 Feb; 32(2):43, 46-9. PubMed ID: 3742585 [No Abstract] [Full Text] [Related]
67. [Treatment of atrial fibrillation with mexiletine in Wolff-Parkinson-White syndrome]. Róna G Z Gesamte Inn Med; 1986 Jun; 41(12):355-8. PubMed ID: 3765734 [TBL] [Abstract][Full Text] [Related]
68. Medical and surgical treatment of the Wolff-Parkinson-White syndrome. Durrer D Annu Rev Med; 1976; 27():63-8. PubMed ID: 938011 [No Abstract] [Full Text] [Related]
69. Drug therapy of heart disease in pediatric patients 3. The therapeutic challenge of supraventricular tachyarrhythmias in infants and children. Rutkowski MM; Doyle EF; Cohen SN Am Heart J; 1973 Oct; 86(4):562-8. PubMed ID: 4728132 [No Abstract] [Full Text] [Related]
70. [The effect of quinidine and novocainamide on auricular flutter and fibrillation and the effectiveness of defibrillatory discharges under experimental conditions]. Babskii EB; Makarychev VA; Orlov VN Kardiologiia; 1973 Mar; 13(3):91-7. PubMed ID: 4717191 [No Abstract] [Full Text] [Related]
71. [2 episodes of ventricular fibrillation in a patient with mild paroxysms of Wolff-Parkinson-White syndrome]. Walczak F; Nyznyk M; Biederman A; Jedynak Z; Bujnowska E Kardiol Pol; 1992 Nov; 37(11):311-3. PubMed ID: 1287293 [TBL] [Abstract][Full Text] [Related]
72. W-P-W syndrome and tachycardia. Gomes de Carvalho A N Engl J Med; 1970 Apr; 282(15):874. PubMed ID: 5418560 [No Abstract] [Full Text] [Related]
73. Acute effect of disopyramide on atrial fibrillation in the Wolff-Parkinson-White syndrome. Fujimura O; Klein GJ; Sharma AD; Yee R; Szabo T J Am Coll Cardiol; 1989 Apr; 13(5):1133-7. PubMed ID: 2926064 [TBL] [Abstract][Full Text] [Related]
74. Precipitation of ventricular fibrillation by intravenous diltiazem and metoprolol in a young patient with occult Wolff-Parkinson-White syndrome. Kim RJ; Gerling BR; Kono AT; Greenberg ML Pacing Clin Electrophysiol; 2008 Jun; 31(6):776-9. PubMed ID: 18507555 [TBL] [Abstract][Full Text] [Related]